Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non‐small cell lung cancer patients-Reference-Cited by-同舟云学术

Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non‐small cell lung cancer patients

Published:2019-11-06 Issue:1 Volume:11 Page:103-112
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Ding Ying¹,Zhang Lihua²,Guo Lingchuan³,Wu Chunyan⁴,Zhou Jianhua⁵,Zhou Yongchun⁶,Ma Jie⁷,Li Xiao¹,Ji Pan¹,Wang Ming²,Zhu Weidong³,Shi Chenxi³,Li Sanen³,Wu Wei⁴,Zhu Wei⁵,Xiao Desheng⁵,Fu Chunyan⁵,He Qiuyan⁵,Sun Rui⁷,Mao Xinru⁸,Lizaso Analyn⁸,Li Bing⁸,Han‐Zhang Han⁸,Zhang Zhihong¹^ORCID

Affiliation:

1. Department of PathologyThe First Affiliated Hospital of Nanjing Medical University Nanjing China

2. Department of PathologySoutheast University, Zhongda Hospital Nanjing China

3. Department of PathologyThe First Affiliated Hospital of Soochow University Suzhou China

4. Department of PathologyShanghai Pulmonary Hospital, Tongji University Shanghai China

5. Department of PathologyXiangya Hospital, Central South University Changsha China

6. Molecular Diagnostic Center, Yunnan Cancer Center, Yunnan Cancer Hospital Kunming China

7. Department of Molecular PathologyThe Affiliated Cancer Hospital of Zhengzhou University Zhengzhou China

8. Burning Rock Biotech Guangzhou China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13208

Reference25 articles.

1. Cancer statistics in China, 2015

2. World Health Organization. [Cited 12 Septemebr 2018.]Cancer Fact Sheet No. 297. World Health Organization. Available from URL:http://www.who.int/mediacentre/factsheets/fs297/en/2018.

3. Personalized therapy on the horizon for squamous cell carcinoma of the lung

4. The 2015 World Health Organization Classification of Lung Tumors

5. Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic profile characterization of histological micropapillary and solid components in lung adenocarcinoma: a systematic review;Journal of Laboratory and Precision Medicine;2024-07

2. Landscape of Clinically Relevant Genomic Alterations in the Indian Non-small Cell Lung Cancer Patients;Clinical Lung Cancer;2024-07

3. Different types of tumor microvessels in stage I-IIIA squamous cell lung cancer and their clinical significance;World Journal of Clinical Oncology;2024-05-24

4. In silico analyses of pan-squamous cell carcinoma unveiled the immunological implications of MRPL13, which had previously been under-recognized;Heliyon;2024-01

5. Landscape of Clinically Relevant Genomic Alterations in the Indian Non-Small Cell Lung Cancer Patients;2024